Switzerland Hormones Sales is set to reach $112.11 Million by 2026 from $104.28 Million 2021, jumped by 2.5% per year. Since 2017, the market increased 6.3% year on year totalising $8,140 Million. The country was number 12 in 2021, Sweden came ahead $104.28 Million. Germany, the United Kingdom and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Switzerland rank in Systemic Hormonal Preparations Sales (Excluding Sex Hormones and Insulins)?
| # | 18 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 2,580 | 2023 | +1.62% | +12.9% | View data |
| 2 | 2 Germany | 1,560 | 2023 | +2.02% | +2.23% | View data |
| 3 | 3 Canada | 533.4 | 2023 | +1.99% | +4.27% | View data |
| 4 | 4 Spain | 466.6 | 2023 | +3.57% | +0.22% | View data |
| 5 | 5 Croatia | 148.7 | 2023 | +2.2% | +0.98% | View data |
| 7 | 7 Sweden | 114.3 | 2023 | +4.19% | -1.84% | View data |
| 8 | 8 Czech Republic | 98 | 2023 | +2.73% | +1.16% | View data |
| 9 | 9 Switzerland | 94.8 | 2023 | +1.72% | +1.52% | |
| 10 | 10 Denmark | 73.1 | 2023 | -0.81% | -1.59% | View data |
| 11 | 11 Ireland | 67.6 | 2023 | +0.15% | +0.15% | View data |
